Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP603342.RAly1zPvOV8Y0vn9yS7iU1gsBLe--hFMg_eq2-34_YnPg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP603342.RAly1zPvOV8Y0vn9yS7iU1gsBLe--hFMg_eq2-34_YnPg130_assertion type Assertion NP603342.RAly1zPvOV8Y0vn9yS7iU1gsBLe--hFMg_eq2-34_YnPg130_head.
- NP603342.RAly1zPvOV8Y0vn9yS7iU1gsBLe--hFMg_eq2-34_YnPg130_assertion description "[Methylation-specific PCR showed that 52.4% of breast tumors were hypermethylated in the CXCL12 promoter region.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP603342.RAly1zPvOV8Y0vn9yS7iU1gsBLe--hFMg_eq2-34_YnPg130_provenance.
- NP603342.RAly1zPvOV8Y0vn9yS7iU1gsBLe--hFMg_eq2-34_YnPg130_assertion evidence source_evidence_literature NP603342.RAly1zPvOV8Y0vn9yS7iU1gsBLe--hFMg_eq2-34_YnPg130_provenance.
- NP603342.RAly1zPvOV8Y0vn9yS7iU1gsBLe--hFMg_eq2-34_YnPg130_assertion SIO_000772 18670789 NP603342.RAly1zPvOV8Y0vn9yS7iU1gsBLe--hFMg_eq2-34_YnPg130_provenance.
- NP603342.RAly1zPvOV8Y0vn9yS7iU1gsBLe--hFMg_eq2-34_YnPg130_assertion wasDerivedFrom befree-20140225 NP603342.RAly1zPvOV8Y0vn9yS7iU1gsBLe--hFMg_eq2-34_YnPg130_provenance.
- NP603342.RAly1zPvOV8Y0vn9yS7iU1gsBLe--hFMg_eq2-34_YnPg130_assertion wasGeneratedBy ECO_0000203 NP603342.RAly1zPvOV8Y0vn9yS7iU1gsBLe--hFMg_eq2-34_YnPg130_provenance.